Changes in body fat associated with obesity can trigger harmful signals to the brain, disrupt immune function, and potentially exacerbate Alzheimer’s disease, according to a new study. The findings offer novel insights into the neurodegenerative condition and suggest potential avenues for early intervention in individuals with metabolic risks for Alzheimer’s.
Information was available with The Chenab Times that the research, published in the journal Molecular Neurodegeneration, moves beyond the conventional understanding of obesity as a general health risk. Obesity, typically characterized by a Body Mass Index (BMI) of 30 or higher, is a metabolic condition linked to increased inflammation and vascular damage, which can elevate the risk of Alzheimer’s disease.
Researchers, primarily from Houston Methodist Hospital in the United States, identified that obesity leads to elevated levels of phosphatidylethanolamines (PEs) – a class of fat molecules – in body tissues. These PEs are then packaged into small particles and transported to the brain.
Once in the brain, these PE particles interfere with communication between neurons, weaken the immune system, and promote the accumulation of amyloid proteins. While amyloid proteins are naturally present in the brain, their clumping into formations is a hallmark of Alzheimer’s disease and a key indicator of neurodegeneration.
According to co-lead researcher Stephen Wong, distinguished chair in biomedical engineering, obesity can alter how signals are transmitted to the brain. He noted that this connection may be treatable, suggesting that the link between obesity and Alzheimer’s risk could be targeted through interventions addressing the specific processes that connect metabolic changes to the brain.
The study utilized an integrated ‘multi-omics’ approach, combining lipidomics, single-nucleus RNA sequencing, proteomics, and high-resolution imaging. This comprehensive method allowed researchers to meticulously map the metabolic alterations occurring in tissues due to obesity.
Functional assessments were conducted using mouse models of Alzheimer’s disease to investigate the brain’s immune responses and behavioral outcomes. The study authors highlighted the crucial role of PE in orchestrating the crosstalk between immune cells and neurons under metabolic stress.
Their findings indicate that lipid remodeling serves as a central structural element connecting obesity to the progression of Alzheimer’s disease. This research supports the potential of lipid-targeted interventions as therapeutic strategies for neurodegeneration associated with metabolic risks.
The Chenab Times News Desk